BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18836791)

  • 1. Prevalence of hepatitis B and C viruses in patients with lymphoproliferative disorders.
    Okan V; Yilmaz M; Bayram A; Kis C; Cifci S; Buyukhatipoglu H; Pehlivan M
    Int J Hematol; 2008 Nov; 88(4):403-408. PubMed ID: 18836791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma.
    Kuniyoshi M; Nakamuta M; Sakai H; Enjoji M; Kinukawa N; Kotoh K; Fukutomi M; Yokota M; Nishi H; Iwamoto H; Uike N; Nishimura J; Inaba S; Maeda Y; Nawata H; Muta K
    J Gastroenterol Hepatol; 2001 Feb; 16(2):215-9. PubMed ID: 11207904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders.
    Shirin H; Davidovitz Y; Avni Y; Petchenko P; Krepel Z; Bruck R; Meytes D
    Isr Med Assoc J; 2002 Jan; 4(1):24-7. PubMed ID: 11802304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of hepatitis G virus infection in Hodgkin's disease and B-cell lymphoproliferative disorders: absence of correlation with hepatitis C virus infection.
    De Renzo A; Persico E; de Marino F; di Giacomo Russo G; Notaro R; di Grazia C; Picardi M; Santoro L; Torella R; Rotoli B; Persico M
    Haematologica; 2002 Jul; 87(7):714-8; discussion 718. PubMed ID: 12091122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C.
    Inokuchi M; Ito T; Uchikoshi M; Shimozuma Y; Morikawa K; Nozawa H; Shimazaki T; Hiroishi K; Miyakawa Y; Imawari M
    J Med Virol; 2009 Apr; 81(4):619-27. PubMed ID: 19235854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
    Resnick RH; Koff R
    Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis B and C markers in glomerular diseases.
    Enríquez R; Rodríguez JC; Sirvent AE; Amorós F; Ardoy F; Alvarez M; Royo G
    Scand J Urol Nephrol; 2007; 41(6):535-8. PubMed ID: 17853005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral genomes and antigen detection of hepatitis B and C viruses in involved lymph nodes of Egyptian non-Hodgkin's lymphoma patients.
    El-Sayed GM; Mohamed WS; Nouh MA; Moneer MM; El-Mahallawy HA
    Egypt J Immunol; 2006; 13(1):105-14. PubMed ID: 17974155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
    Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
    Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia.
    Luppi M; Grazia Ferrari M; Bonaccorsi G; Longo G; Narni F; Barozzi P; Marasca R; Mussini C; Torelli G
    Leukemia; 1996 Feb; 10(2):351-5. PubMed ID: 8637247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France.
    Hausfater P; Cacoub P; Sterkers Y; Thibault V; Amoura Z; Nguyen L; Ghillani P; Leblond V; Piette JC
    Am J Hematol; 2001 Jul; 67(3):168-71. PubMed ID: 11391713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies.
    Dal Maso L; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2078-85. PubMed ID: 17119031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations of hematological parameters with bone marrow findings in chronic lymphoproliferative disorders associated with hepatitis viruses.
    Ciufu C; Arama V; Bumbea H; Dobrea C; Ion I; Vladareanu AM
    J Med Life; 2013; 6(4):464-71. PubMed ID: 24868264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy.
    De Rosa G; Gobbo ML; De Renzo A; Notaro R; Garofalo S; Grimaldi M; Apuzzo A; Chiurazzi F; Picardi M; Matarazzo M; Rotoli B
    Am J Hematol; 1997 Jun; 55(2):77-82. PubMed ID: 9209002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders.
    Realdon S; Pontisso P; Adami F; Trentin L; Noventa F; Ferrari A; Migliorato I; Gatta A; Alberti A
    J Hepatol; 2001 May; 34(5):723-9. PubMed ID: 11434619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles.
    Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM
    Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders.
    Silvestri F; Pipan C; Barillari G; Zaja F; Fanin R; Infanti L; Russo D; Falasca E; Botta GA; Baccarani M
    Blood; 1996 May; 87(10):4296-301. PubMed ID: 8639788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH.
    Nieters A; Kallinowski B; Brennan P; Ott M; Maynadié M; Benavente Y; Foretova L; Cocco PL; Staines A; Vornanen M; Whitby D; Boffetta P; Becker N; De Sanjosé S
    Gastroenterology; 2006 Dec; 131(6):1879-86. PubMed ID: 17087949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.